Skip to main content

Table 1 TSQM Validation Survey: Respondent Characteristics (n = 567)

From: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

Illness Group Major Route of Admin: Total (%) Weeks on Medication Mean (SD) Health Rating+ Mean (SD) Illness Severity++ Mean (SD)
Migraine (n = 68) Oral: 60 (88.2%) 57.2 (76.4) 2.8 (.8) 1.9 (.6)
Arthritis (n = 75) Oral: 71 (94.7%) 38.2 (40.4) 2.9 (.9) 1.9 (.6)
High BP (n = 76) Oral: 76 (100%) 52.1 (53.2) 2.5 (.8) 1.7 (.6)
Asthma (n = 72) Inhaled: 62(86.1%) 92.4 (114.8) 2.9 (1.0) 1.8 (.7)
Diabetes (n = 63) Injected: 53 (84.1%) 125.0 (115.4) 3.4 (.9) 2.2 (.5)
Psoriasis (n = 63) Topical: 53 (84.1%) 49.7 (60.1) 2.9 (.9) 1.7 (.6)
High Cholesterol (n = 75) Oral: 75 (100%) 31.0 (34.7) 2.8 (1.0) 2.0 (.6)
Depression (n = 75) Oral: 75 (100%) 42.9 (42.7) 2.6 (.9) 2.1 (.5)
  1. +1 = Excellent, 2 = Very Good, 3 = Good, 4 = Fair, 5 = Poor; ++1 = Mild, 2 = Moderate, 3 = Severe